|
|
|
|
|
|
|
|
|||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
Journal of Cell Science, Vol 109, Issue 7 1749-1757, Copyright © 1996 by Company of Biologists
JOURNAL ARTICLES |
N Soussi-Yanicostas, JP Hardelin, MM Arroyo-Jimenez, O Ardouin, R Legouis, J Levilliers, F Traincard, JM Betton, L Cabanie and C Petit
Unite de Genetique Moleculaire Humaine (CNRS URA 1968), Institut Pasteur, Paris, France.
The KAL gene is responsible for the X-chromosome linked form of Kallmann's syndrome in humans. Upon transfection of CHO cells with a human KAL cDNA, the corresponding encoded protein, KALc, was produced. This protein is N-glycosylated, secreted in the cell culture medium, and is localized at the cell surface. Several lines of evidence indicate that heparan-sulfate chains of proteoglycan(s) are involved in the binding of KALc to the cell membrane. Polyclonal and monoclonal antibodies to the purified KALc were generated. They allowed us to detect and characterize the protein encoded by the KAL gene in the chicken central nervous system at late stages of embryonic development. This protein is synthesized by definite neuronal cell populations including Purkinje cells in the cerebellum, mitral cells in the olfactory bulbs and several subpopulations in the optic tectum and the striatum. The protein, with an approximate molecular mass of 100 kDa, was named anosmin-1 in reference to the deficiency of the sense of smell which characterizes the human disease. Anosmin-1 is likely to be an extracellular matrix component. Since heparin treatment of cell membrane fractions from cerebellum and tectum resulted in the release of the protein, we suggest that one or several heparan-sulfate proteoglycans are involved in the binding of anosmin-1 to the membranes in vivo.
This article has been cited by other articles:
|
|
 |
|
  D. Gonzalez-Martinez, S.-H. Kim, Y. Hu, S. Guimond, J. Schofield, P. Winyard, G. B. Vannelli, J. Turnbull, and P.-M. Bouloux Anosmin-1 Modulates Fibroblast Growth Factor Receptor 1 Signaling in Human Gonadotropin-Releasing Hormone Olfactory Neuroblasts through a Heparan Sulfate-Dependent Mechanism J. Neurosci., November 17, 2004; 24(46): 10384 - 10392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cariboni, F. Pimpinelli, S. Colamarino, R. Zaninetti, M. Piccolella, C. Rumio, F. Piva, E. I. Rugarli, and R. Maggi The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of gonadotropin-releasing hormone (GnRH)-producing neurons Hum. Mol. Genet., November 15, 2004; 13(22): 2781 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Sato, N. Katsumata, M. Kagami, T. Hasegawa, N. Hori, S. Kawakita, S. Minowada, A. Shimotsuka, Y. Shishiba, M. Yokozawa, et al. Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (KAL1) and Fibroblast Growth Factor Receptor 1 (FGFR1, or KAL2) in Five Families and 18 Sporadic Patients J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1079 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. Bulow, K. L. Berry, L. H. Topper, E. Peles, and O. Hobert Heparan sulfate proteoglycan-dependent induction of axon branching and axon misrouting by the Kallmann syndrome gene kal-1 PNAS, April 30, 2002; 99(9): 6346 - 6351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Key and J. St John Axon Navigation in the Mammalian Primary Olfactory Pathway: Where to Next? Chem Senses, March 1, 2002; 27(3): 245 - 260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Allen, D. A. Linseman, H. Udo, M. Xu, J. B. Schaack, B. Varnum, E. R. Kandel, K. A. Heidenreich, and M. E. Wierman Novel Mechanism for Gonadotropin-Releasing Hormone Neuronal Migration Involving Gas6/Ark Signaling to p38 Mitogen-Activated Protein Kinase Mol. Cell. Biol., January 15, 2002; 22(2): 599 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. Persson, K. Humphrey, C. Watson, P. Taylor, D. Leigh, B. McDonald, and I. S. Fraser Investigation of a unique male and female sibship with Kallmann's syndrome and 46,XX gonadal dysgenesis with short stature Hum. Reprod., May 1, 1999; 14(5): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Krams, R. Quinton, J. Ashburner, K. J. Friston, R. S. J. Frackowiak, P.-M. G. Bouloux, and R. E. Passingham Kallmann's syndrome: Mirror movements associated with bilateral corticospinal tract hypertrophy Neurology, March 1, 1999; 52(4): 816 - 816. [Abstract] [Full Text]
|
|
|
|
 |
|
 U Muller and A. Brandli Cell adhesion molecules and extracellular-matrix constituents in kidney development and disease J. Cell Sci., January 11, 1999; 112(22): 3855 - 3867. [Abstract] [PDF]
|
|
|
|
 |
|
 S. B. Seminara, F. J. Hayes, and W. F. Crowley Jr. Gonadotropin-Releasing Hormone Deficiency in the Human (Idiopathic Hypogonadotropic Hypogonadism and Kallmann's Syndrome): Pathophysiological and Genetic Considerations Endocr. Rev., October 1, 1998; 19(5): 521 - 539. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. D. Eudy, M. D. Weston, S. Yao, D. M. Hoover, H. L. Rehm, M. Ma-Edmonds, D. Yan, I. Ahmad, J. J. Cheng, C. Ayuso, et al. Mutation of a Gene Encoding a Protein with Extracellular Matrix Motifs in Usher Syndrome Type IIa Science, June 12, 1998; 280(5370): 1753 - 1757. [Abstract] [Full Text]
|
|
|
|
|
|
N Soussi-Yanicostas, C Faivre-Sarrailh, J. Hardelin, J Levilliers, G Rougon, and C Petit Anosmin-1 underlying the X chromosome-linked Kallmann syndrome is an adhesion molecule that can modulate neurite growth in a cell-type specific manner J. Cell Sci., January 10, 1998; 111(19): 2953 - 2965. [Abstract] [PDF]
|
|
|
|
 |
|
 R. D. Fields Cell Adhesion Molecules: Implications for Neurological Disease Neuroscientist, January 1, 1998; 4(1): 4 - 8. [PDF]
|
|
|
|
 |
|
 A Varela-Echavarria and S Guthrie Molecules making waves in axon guidance. Genes & Dev., March 1, 1997; 11(5): 545 - 557. [PDF]
|
|
